Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Magellan Health Reaffirms FY20 Guidance: Adj. EPS $0.63-$1.10 vs $0.91 Estimate, Sales $4.4B-$4.6B vs $4.5B Est.


Benzinga | Oct 29, 2020 06:47AM EDT

Magellan Health Reaffirms FY20 Guidance: Adj. EPS $0.63-$1.10 vs $0.91 Estimate, Sales $4.4B-$4.6B vs $4.5B Est.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC